Results about: innovation
IRB Barcelona starts a project with the long-term goal to achieve an injectable frataxin treatment able to reach the brain.
Frataxin is the protein that is reduced in those affected by this rare and degenerative disease, which has no cure.
The patients’ associations Babel Family and ASOGAF in Granada provide the funding for the initial 18 months of this challenge.
IRB Barcelona and Merus form a research collaboration to develop antibodies targeting the tumor microenvironment
The research collaboration will combine Merus’ Biclonics technology platform and unique cell and animal models at the Colorectal Cancer Laboratory led by Eduard Batlle to investigate the stroma.
ICREA researcher and group leader of the Stem Cells and Cancer Laboratory at IRB Barcelona receives an award for his work on cancer.
The prize acknowledges Salvador Aznar Benitah's contributions to transferring knowledge from basic to clinical research.